Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 27% ± 5% | |
| dendritic cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of DNAJC30 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 561.50 | 226 / 226 | 100% | 16.37 | 406 / 406 |
| ovary | 100% | 523.47 | 180 / 180 | 100% | 26.01 | 430 / 430 |
| thymus | 100% | 839.13 | 653 / 653 | 100% | 31.18 | 605 / 605 |
| kidney | 100% | 731.20 | 89 / 89 | 100% | 19.78 | 900 / 901 |
| esophagus | 100% | 511.72 | 1443 / 1445 | 100% | 14.20 | 183 / 183 |
| brain | 100% | 728.01 | 2638 / 2642 | 100% | 19.18 | 705 / 705 |
| skin | 100% | 511.54 | 1806 / 1809 | 100% | 22.45 | 472 / 472 |
| prostate | 100% | 631.33 | 245 / 245 | 100% | 27.45 | 501 / 502 |
| bladder | 100% | 543.38 | 21 / 21 | 100% | 17.17 | 502 / 504 |
| adrenal gland | 100% | 1199.37 | 258 / 258 | 100% | 22.43 | 229 / 230 |
| intestine | 100% | 502.01 | 965 / 966 | 100% | 15.23 | 525 / 527 |
| breast | 100% | 557.22 | 459 / 459 | 99% | 20.66 | 1112 / 1118 |
| pancreas | 99% | 379.50 | 326 / 328 | 100% | 14.42 | 178 / 178 |
| stomach | 100% | 431.63 | 358 / 359 | 100% | 14.06 | 285 / 286 |
| uterus | 100% | 537.95 | 170 / 170 | 98% | 14.20 | 452 / 459 |
| lung | 92% | 371.08 | 533 / 578 | 100% | 16.62 | 1152 / 1155 |
| adipose | 100% | 525.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 25.15 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 22.28 | 29 / 29 |
| spleen | 100% | 524.01 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 11.49 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.92 | 1 / 1 |
| blood vessel | 99% | 382.36 | 1323 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 445.92 | 790 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 644.89 | 839 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 61% | 213.04 | 567 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007420 | Biological process | brain development |
| GO_1905706 | Biological process | regulation of mitochondrial ATP synthesis coupled proton transport |
| GO_0006754 | Biological process | ATP biosynthetic process |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | DNAJC30 |
| Protein name | DnaJ homolog subfamily C member 30, mitochondrial (Williams-Beuren syndrome chromosomal region 18 protein) |
| Synonyms | WBSCR18 |
| Description | FUNCTION: Mitochondrial protein enriched in neurons that acts as a regulator of mitochondrial respiration (By similarity). Associates with the ATP synthase complex and facilitates ATP synthesis (By similarity). May be a chaperone protein involved in the turnover of the subunits of mitochondrial complex I N-module. It facilitates the degradation of N-module subunits damaged by oxidative stress, and contributes to complex I functional efficiency . . |
| Accessions | ENST00000395176.3 Q96LL9 |